Multiple flow path device for oral delivery of discrete units

• US 5,910,321 A
• Filed: 10/14/1997
• Issued: 06/08/1999
• Est. Priority Date: 10/18/1996
• Status: Expired due to Term

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Wong, Patrick S.-L., Ferrari, Vincent J., Roth, Nathan
• Primary Examiner(s): Page, Thurman K.
• Assistant Examiner(s): CHANNAVAJJALA, LAKSHMI SARADA
• Application Number:
  US08/949,753
• Time in Patent Office: 602 Days
• Field of Search: 424/464, 424/468, 424/473, 424/489, 604/83, 604/84, 222/476, 222/477, 222/478, 239/33
• US Class Current: 424/473
• CPC Class Codes: A47G 21/183 with means for changing the flavour of the liquid
• CPC Class Codes: A61J 7/0038 Straws
• CPC Class Codes: A61K 9/0004 Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Abstract

The present invention is directed to an oral active agent delivery system and method for delivering discrete units of an active agent to a patient. An elongate tubular member having first and second ends comprises first and second flow paths. Either or both of said flow paths contains an active agent. Liquid is drawn up into the first end of the member, and the liquid and active agent is drawn out of the second end of the member and into the patient'"'"'s mouth.

Claims

1. A device for administering one or more active agents to a patient, comprising:

an elongate tubular member having a first end and a second end and comprising a first and a second flow path, wherein at least one of said flow paths contains a quantity of discrete units that comprise an active agent, wherein said first end is configured so that said flow paths are adapted for fluid communication with an external fluid, and said second end is configured for oral application of suction by the patient so that the quantity of discrete units is entrained in the fluid that is drawn into the device by the patient.

2. The device of claim 1 wherein, said at least one flow path contains a fluid passing active agent retainer.

3. The device of claim 2 wherein said active agent retainer comprises a grid.

4. The device of claim 2 wherein said active agent retainer comprises a narrowing in the first end of the elongate tubular member.

5. The device of claim 4 wherein the active agent retainer further comprises a plug.

6. The device of claim 1 wherein said discrete units are selected from the group consisting of particulates, oral dosage forms and combinations thereof.

7. The device of claim 1, wherein said discrete units provide for prolonged delivery of the active agent.

8. The device of claim 1 wherein said discrete units provide for immediate delivery of the active agent.

9. The device of claim 1 wherein said discrete units provide for delayed pulsed delivery of said active agent.

10. The device of claim 1, further comprising an end cap concentrically surrounding the second end of the elongated tubular member.

11. The device of claim 1, wherein said active agent is selected from the group consisting of antibiotics, antiviral agents, anepileptics, analgesics, and anti-inflammatory agents, and bronchodilators.

12. The device of claim 1, further comprising a third, fourth and fifth flow path, each of which is adapted for fluid communication with the fluid.

13. The device of claim 12 wherein said at least one flow path has a diameter larger than that of any of the second, third, fourth and fifth flow paths.

14. The device of claim 1 further comprising third and fourth flow paths, adapted for fluid communication with the fluid, having diameters that are smaller than the first and second flow paths.

15. The device of claim 1 further comprising a third flow path adapted for fluid communication with the fluid with a diameter that is smaller than the first and second flow paths.

16. The device of claim 1, further comprising seven additional flow paths, each of which is adapted for fluid communication with the fluid, the first flow path being larger than any of the other flow paths.

17. The device of claim 1, further comprising a quantity of discrete units that comprise a second active agent disposed in the other of said flow paths.

21. The device of claim 1, wherein the quantity of discrete units comprises between 100 and 5000 mg of the active agent.

18. A method for administering one or more active agents to a patient comprising:

a. entraining discrete units of an active agent contained in a delivery device in an external fluid that is drawn into the delivery device by the patient and introducing the entrained units into the mouth of the patient; and

b. simultaneously introducing a supplemental stream of fluid into the mouth of the patient.

19. The method of claim 18 wherein the supplemental stream of fluid comprises an active agent that is the same as or different from the entrained units of active agent.

20. The method of claim 18 wherein the supplemental stream of fluid does not contain an active agent.